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Kidney disease and 
thrombocytopenia in mice with a 
mutation in the C1galt1 gene
Compromised glycoprotein-N-acetylgalactosamine-3-β-
galactosyltransferase (core 1 β1,3-galactosyltransferase, 
C1GalT1) activity has been associated with IgA 
nephropathy, a common glomerulonephritis. C1GalT1 
generates the core 1 disaccharide O-glycan Galβ1–
3GalNAcα1-Ser/Thr, also known as the T antigen, which 
is the precursor for the synthesis of many of the extended 
mucin-type O-glycans found on mammalian glycoproteins. 
The embryonic lethality in knockout mice lacking C1GalT1 
has prevented the development of effective animal models 
of C1GalT1 defi ciency in adult physiology and disease.
Alexander and co-workers have used N-ethyl-N-
nitrosourea (a potent, random mutagen of the mouse 
germ line that induces heritable DNA changes) and 
breeding schemes to establish mice with dominant and 
recessive phenotypes in which the causative mutations 
can be genetically mapped. Now, they describe recessively 
inherited thrombocytopenia and kidney disease in plt1 
mice, which have an N-ethyl-N-nitrosourea-induced point 
mutation in the gene encoding C1GalT1 and express very 
low enzymatic activity. All major organs in plt1/plt1 mice 
were histologically normal with the exception of the kidney, 
which displayed lesions affecting clusters of glomeruli and 
their corresponding proximal tubules; the latter showed 
fatty degeneration and contained protein casts (see Figure). 
The mice had albuminuria from an early age and became 
ill from about 10 weeks of age, and 90% were moribund 
by 200 days. Sick mice had high urea and creatinine levels 
in serum, and their kidneys exhibited cortical atrophy, 
glomerular loss, and infl ammatory infi ltration.
This study shows indispensable roles of C1GalT1 in 
thrombopoiesis and kidney homeostasis. However, because 
the O-linked glycosylation sites in the hinge region of 
human IgA are not conserved in the mouse, this mechanism 
is unlikely to underlie kidney disease in plt1/plt1 mice. 
Although reduced C1GalT1 activity has been shown clearly 
in B cells from IgA nephropathy patients, the phenotype of 
plt1/plt1 mice suggests that reduced C1GalT1 activity in the 
kidney may cause renal pathology independent of immune 
effects. Thus, the potential contribution of intrinsic 
defi ciency in C1GalT1 to renal disease may be worthy of 
closer examination in IgA nephropathy and other kidney 
disorders. (Proc Natl Acad Sci USA 2006; 103: 16442–16447)
Juan Oliver
Uric acid and the development of 
hypertension
In experimental animals, hyperuricemia induces high 
blood pressure that corrects with hypouricemic therapy, 
suggesting that uric acid may have a pathogenic role in 
hypertension. In humans, an elevated serum uric acid level 
has long been associated with increased risk of developing 
hypertension, but it remained unresolved whether this 
association is because of underlying renal, metabolic, or 
other abnormalities.
Perlstein et al.1 used the Normative Aging Study, a 
longitudinal study of healthy adult men begun in 1963 
and with ongoing follow-up, to examine the relationship 
between serum uric acid level and the development of 
hypertension. The duration of follow-up (≤40 years) 
allowed them to assess the durability of the association, 
and the comprehensive data collected allowed adjustment 
for key potential confounding covariates, such as central 
adiposity, alcohol intake, metabolic parameters, and the 
serum creatinine level. Of the 2,280 initial men in the study, 
2,062 had available information for inclusion in the analysis. 
The Cox proportional hazards model was used to examine 
the relationship between baseline serum uric acid level and 
the development of hypertension, adjusting for age, body 
mass index, abdominal circumference, smoking, alcohol, 
plasma triglycerides, total cholesterol, and plasma glucose. 
A total of 892 men developed hypertension over a mean of 
21.5 years of follow-up. Serum uric acid level independently 
predicted the development of hypertension. Among 1,277 
men at risk for the development of hypertension at the 
time of their fi rst serum creatinine measurement, 508 
(39.8%) developed hypertension over a mean of 10.3 years 
of follow-up. With an additional adjustment for calculated 
glomerular fi ltration rate in this subset, serum uric acid 
remained associated with the development of hypertension. 
Thus, the baseline serum uric acid level is a marker of risk 
Kidney sections from a sick plt1/plt1 and healthy controls, illustrating 
the extensive inflammatory infiltration, loss of glomeruli, and tubular 
disorganization in the plt1/plt1 kidneys.
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for the development of hypertension, and the association 
is independent of elements of the metabolic syndrome, 
alcohol intake, and renal function.
In a related study, Mellen et al.2 examined the participants 
(N = 9104) in the Atherosclerosis Risk in Communities 
study who were free of hypertension at baseline and 
evaluated them for hypertension at 3-year intervals over 
four examinations. Adjusted Cox proportional hazards 
models evaluated risk of incident hypertension or 
progression of blood category for each standard deviation 
higher than baseline serum uric acid. Higher serum uric 
acid was associated with greater risk of hypertension in the 
overall cohort and in subgroup analyses (black men, black 
women, white men, and white women), after adjustment 
for age, baseline blood pressure, body mass index, renal 
function, diabetes, and smoking. The pattern was similar 
when blood pressure progression was modeled.
These studies show that serum uric acid level is a durable 
and strong predictor of the development of hypertension. 
(1Hypertension 2006; 48: 1031–1036. 2Hypertension 2006; 
48: 1037–1042)
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Wnk4 controls blood pressure 
and potassium homeostasis via 
regulation of mass and activity of 
the distal convoluted tubule
Pseudohypoaldosteronism type II (Gordon syndrome) 
is characterized by hypertension and hyperkalemia, and 
recent studies identifi ed a mutation in a protein kinase 
termed Wnk4. Early physiological studies have suggested 
that there is increased Cl absorption in this syndrome, and 
since the identifi cation of the mutant protein it was found 
that Wnk4 aff ects the endocytosis of the thiazide-sensitive 
Na-Cl cotransporter in the distal convoluted tubule. In a 
recent paper, Lalioti et al. compared the renal handling of 
K in several lines of mice. Mice that lacked both copies of 
Wnk4 were made transgenic with wild-type and mutant 
Wnk4. Mice that now harbored the mutant Wnk4, when 
compared with those that expressed the wild type, had 
hypertension, hyperkalemia, hypercalciuria, and marked 
hyperplasia of the distal convoluted tubule (see Figure). 
(Strictly speaking, the authors did not show that the 
number of cells in these tubules was greater than that in the 
appropriate controls, but the lumens of these tubules were 
clearly larger and seemed to have thicker cells.) When these 
animals were crossed with those that lacked the distal-tubule 
Na-Cl cotransporter, all of these anomalies were reversed, 
indicating that increased salt absorption in this segment 
was the cause of the hypertension and hyperkalemia. Th ese 
studies have many implications for the regulation of K (and 
also, incidentally, H+) secretion by the kidney, showing the 
critical role of upstream absorption in the control of Na 
delivery to the collecting tubule. In addition, they show the 
eff ect of the rate of Na absorption in the distal convoluted 
tubule on the size and shape of the epithelial cell. (Nat Genet 
2006; 38: 1124–1132)
Qais Al-Awqati
Toll-like receptor triggering of 
a vitamin D-mediated human 
antimicrobial response
Treatment with active forms of vitamin D ameliorates 
abnormalities in bone and mineral metabolism. In addition, 
vitamin D seems to be associated with reduced risk for 
cardiovascular death in patients with end-stage renal failure, 
indicating a polyvalent activity of vitamin D. A recent paper 
in Science adds a new dimension to this polyvalence of active 
vitamin D. Since the late 1800s, sunlight and other forms 
of light therapy have been considered potentially benefi cial 
for tuberculosis, most likely because of the antimicrobial 
eff ects of sunlight-induced synthesis of vitamin D. Liu et al. 
reveal that vitamin D signaling contributes to the Toll-like 
receptor (TLR) pathway of microbicidal defense against 
Mycobacterium tuberculosis in monocytes and macrophages. 
Activation of TLR2/1 by a bacterial lipoprotein led to 
vitamin D receptor expression and processing of the 
provitamin D precursor, which stimulated vitamin 
D-induced upregulation of an antimicrobial peptide, 
cathelicidin, and killing of Mycobacterium tuberculosis 
bacilli. Th e low levels of circulating provitamin D3 hormone 
and limited ability to induce the microbicidal peptide that 
are observed in sera of African-American individuals may 
contribute to their increased susceptibility to tuberculosis. 
(Science 2006; 311: 1770–1773)
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Alteration of distal convoluted tubule morphology by Wnk4. NCC, Na-Cl 
cotransporter of the distal convoluted tubule.
